ZA971070B - Transfectant composition useful in gene therapy asA water control gate. sociating with a recombinant virus incorporating an exogenous nucleic acid and a non-viral and non-plasmid transfection agent. - Google Patents

Transfectant composition useful in gene therapy asA water control gate. sociating with a recombinant virus incorporating an exogenous nucleic acid and a non-viral and non-plasmid transfection agent.

Info

Publication number
ZA971070B
ZA971070B ZA9701070A ZA971070A ZA971070B ZA 971070 B ZA971070 B ZA 971070B ZA 9701070 A ZA9701070 A ZA 9701070A ZA 971070 A ZA971070 A ZA 971070A ZA 971070 B ZA971070 B ZA 971070B
Authority
ZA
South Africa
Prior art keywords
sociating
transfectant
viral
nucleic acid
control gate
Prior art date
Application number
ZA9701070A
Inventor
Nathalie Aubailly Pe Townshend
Didier Branellec
Nathalie Ratet
Patrick Benoit
Abderrahim Mahfoudi
Original Assignee
Rhone Poulenc Rorer S A Peter
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9614693A external-priority patent/FR2756491B1/en
Application filed by Rhone Poulenc Rorer S A Peter filed Critical Rhone Poulenc Rorer S A Peter
Priority to ZA9701070A priority Critical patent/ZA971070B/en
Publication of ZA971070B publication Critical patent/ZA971070B/en

Links

ZA9701070A 1996-02-12 1997-02-10 Transfectant composition useful in gene therapy asA water control gate. sociating with a recombinant virus incorporating an exogenous nucleic acid and a non-viral and non-plasmid transfection agent. ZA971070B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ZA9701070A ZA971070B (en) 1996-02-12 1997-02-10 Transfectant composition useful in gene therapy asA water control gate. sociating with a recombinant virus incorporating an exogenous nucleic acid and a non-viral and non-plasmid transfection agent.

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ZA961109 1996-02-12
FR9614693A FR2756491B1 (en) 1996-11-29 1996-11-29 TRANSFECTING COMPOSITION USEFUL IN GENE THERAPY ASSOCIATED WITH A RECOMBINANT VIRUS INCORPORATING EXOG ENE NUCLEIC ACID, A NON-VIRAL AND NON-PLASMIDIC TRANSFECTING AGENT
ZA9701070A ZA971070B (en) 1996-02-12 1997-02-10 Transfectant composition useful in gene therapy asA water control gate. sociating with a recombinant virus incorporating an exogenous nucleic acid and a non-viral and non-plasmid transfection agent.

Publications (1)

Publication Number Publication Date
ZA971070B true ZA971070B (en) 1997-08-25

Family

ID=27253262

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9701070A ZA971070B (en) 1996-02-12 1997-02-10 Transfectant composition useful in gene therapy asA water control gate. sociating with a recombinant virus incorporating an exogenous nucleic acid and a non-viral and non-plasmid transfection agent.

Country Status (1)

Country Link
ZA (1) ZA971070B (en)

Similar Documents

Publication Publication Date Title
PT607206E (en) COMPOSITION FOR THE INTRODUCTION OF NUCLEIC ACID COMPLEXES IN HIGHER EUCARY CELLS
CA2161136A1 (en) Adenoviruses having modified fiber proteins
UA66417C2 (en) Recombinant adenovirus affecting canines, pharmaceutical composition
CA2311643A1 (en) Compositions and methods for inducing gene expression
AU7177896A (en) Multidrug resistance gene
HK1028347A1 (en) Pharmaceutical antiviral composition comprising glycyrrhizic acid and at least one protein endowed with antiviral activity
IL117116A0 (en) A medical composition for the in vivo transfection and expression of exogenes
ZA971070B (en) Transfectant composition useful in gene therapy asA water control gate. sociating with a recombinant virus incorporating an exogenous nucleic acid and a non-viral and non-plasmid transfection agent.
AU7401098A (en) Transfectant composition useful in gene therapy associating with a recombinant virus incorporating an exogenous nucleic acid and a non-viral and non-plasmid transfection agent
IL117466A0 (en) Recombinant viruses expressing lecithin-cholesterol acryltransferase and their use in gene therapy
GB9817660D0 (en) Adenoviral vectors encoding erythropoietin and their use in gene therapy
AU1814995A (en) Galanin receptor, nucleic acids, transformed cells and uses thereof
MX9702078A (en) Adenovirus-derived viral vectors having two therapeutic genes: suicide and immunopotentiating.
EP0763205A4 (en) Nucleic acid sequences controlling lung cell-specific gene expression
ZA997213B (en) Gene delivery vectors provided with a tissue tropism for smooth muscle cells, and/or endothelial cells.
AU2294899A (en) Stress promoter control of therapeutic genes in gene therapy: compositions and methods
AU6346898A (en) Gene therapy using bone marrow transplants transfected with therapeutic genes under the control of tissue-specific promoters
EP1593742A3 (en) Recombinant adenoviral vectors expressing chimeric fiber proteins for cell specific infection
GB9604714D0 (en) Recombinant bovine adenovirus vector system and its application in gene therapy and in the development of recombinant vaccine
雷虹 et al. THE EFFECTOR FUNCTIONS OF MACROPHAGES TRANSFECTED WITH INTERFERON-GAMMA GENE MEDIATED BY RECOMBINANT ADENOVIRUS
SI0980254T1 (en) Pharmaceutical antiviral composition comprising glycyrrhizic acid and at least one protein endowed with antiviral activity
鈴木文子 Bacterial lipase and high-fat diets in canine exocrine pancreatic insufficiency: a new therapy of steatorrhea?
Asai Bioethical Decisions Concerning the End of Life in Japan: Life-sustaining Treatment, Priority of Patients' Preferences, and Cross-Cultural Differences
AU5217100A (en) Adenoviral vectors encoding interferon and their use in gene therapy
AU2003200630A1 (en) Mammalian genes involved in viral infection and tumor suppression